Page last updated: 2024-10-21

acebutolol and Osteoporosis

acebutolol has been researched along with Osteoporosis in 1 studies

Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.

Osteoporosis: Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, B1
Pan, JX1
Yu, H1
Xiong, L1
Zhao, K1
Xiong, S1
Guo, JP1
Lin, S1
Sun, D1
Zhao, L1
Guo, H1
Mei, L1
Xiong, WC1

Other Studies

1 other study available for acebutolol and Osteoporosis

ArticleYear
Lack of Myosin X Enhances Osteoclastogenesis and Increases Cell Surface Unc5b in Osteoclast-Lineage Cells.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2019, Volume: 34, Issue:5

    Topics: Acebutolol; Animals; HEK293 Cells; Humans; Mice; Mice, Knockout; Myosins; Netrin Receptors; Netrin-1

2019